About Acubiosys Private Limited
Data last updated:
Acubiosys Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 08 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2017PTC115047. Its GSTIN is 36AAPCA3353G1ZM (Telangana).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹59.5 Lakh. It is led by directors Srinivasa Rao Maddi and Raja Kumari Velpuri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. D – 14/A Ida Moulali, Hyderabad, Telangana, India – 500040.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.05 Cr, a growth of 41% compared to the previous year. For the same year it recorded a net profit of ₹20.03 Lakh (net margin 9.8%) and EBITDA of ₹42.81 Lakh (EBITDA margin 20.9%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 31% over five years.
The company is associated with 1 brand: Acubiosys. As per MCA filings, the company has open charges of ₹81 Lakh on record. The company has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2020. Its 10 peer companies in the Biotechnology industry (Biotechnology) are compared by revenue, 5 larger and 5 smaller; the largest is Sekkei Bio Private Limited with revenue of ₹2.13 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website acubiosys.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No. D – 14/A Ida Moulali, Hyderabad, Telangana, India – 500040
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Acubiosys Private Limited
The main business activity of Acubiosys is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Acubiosys Private Limited FY 2025 filings available
Acubiosys Private Limited reported revenue of ₹2.05 Cr (up 41% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Acubiosys Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 31% over five years, including 41% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Acubiosys Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹42.81 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹20.03 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Acubiosys Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Acubiosys are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Acubiosys Private Limited
Acubiosys Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sekkei Bio Private Limited | ₹2.13 Cr (FY 2024) | •••• | •••• | 4734.0% | •••• | Chennai, Tamil Nadu, India |
| Vasanthu Biotech Private Limited | ₹2.12 Cr (FY 2025) | •••• | •••• | -35.0% | •••• | Hyderabad, Telangana, India |
| Avisa Biotech Private Limited | ₹2.11 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Virar West, Maharashtra, India |
| Relic Biotechnology Private Limited | ₹2.09 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Pune, Maharashtra, India |
| Nopo Nanotechnologies India Private Limited | ₹2.06 Cr (FY 2025) | •••• | •••• | 428.0% | •••• | Bengaluru, Karnataka, India |
| Acubiosys Private Limited this company | ₹2.05 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Hyderabad, Telangana, India |
| Diagnomics (OPC) Private Limited | ₹2.05 Cr (FY 2024) | •••• | •••• | 44.0% | •••• | Chennai, Tamil Nadu, India |
| Microbial Mining Biotech Private Limited | ₹2.04 Cr (FY 2024) | •••• | •••• | -34.0% | •••• | Bangalore, Karnataka, India |
| Aaria Bio - Lifesciences Research Private Limited | ₹2.03 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Pune, Maharashtra, India |
| Apac Biotech Private Limited | ₹1.99 Cr (FY 2024) | •••• | •••• | 72.0% | •••• | New Delhi, Delhi, India |
| Hydrolina Biotech Private Limited | ₹1.98 Cr (FY 2019) | •••• | •••• | 10305.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Acubiosys by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Acubiosys Private Limited
Acubiosys Private Limited is audited by V KISHORE & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V KISHORE & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Acubiosys Private Limited
Acubiosys has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Rao Maddi Also directs: MLR Pharma LLP | Director | 08 Feb 2017 | 9 Years 8 Months | Current |
| Raja Kumari Velpuri Also directs: MLR Pharma LLP | Director | 08 Feb 2017 | 9 Years 8 Months | Current |
Ownership and Shareholding of Acubiosys Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Acubiosys Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Aug 2020 | Others | ₹81 Lakh | Open |
Total charge records: 1 View all charges
Deals & Funding of Acubiosys Private Limited
Acubiosys Private Limited has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2020.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Sep 2018 | Rights issue | ₹29 Lakh | Investors: 4 individuals |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Associated Brands with Acubiosys Private Limited
Acubiosys operates one associated brand: Acubiosys. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Research and development based company focused on the development of drugs | acubiosys.com |
Employees and EPFO Compliance at Acubiosys Private Limited
Employment history and EPFO contributions of people linked to Acubiosys.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
News related to Acubiosys Private Limited
Recent Activity on Acubiosys Private Limited
Acubiosys Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Sreenivasa Kalyan Velpuri ceased to be Additional Director on 19 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Acubiosys Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Acubiosys Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Acubiosys Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Acubiosys Private Limited
Acubiosys has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAPCA3353G1ZM | Telangana | Active | 09 Apr 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Acubiosys Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acubiosys Private Limited
Acubiosys is an active private limited company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 08 February 2017 (9+ years old) and is registered under CIN U73100TG2017PTC115047.
Acubiosys reported revenue of ₹2.05 Cr for FY 2025 (up 41% YoY).
Acubiosys has 2 current directors:
- Srinivasa Rao Maddi - Director
- Raja Kumari Velpuri - Director
Acubiosys reported a net profit of ₹20.03 Lakh (net margin 9.8%) and EBITDA of ₹42.81 Lakh (EBITDA margin 20.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Acubiosys is 34% over three years and 31% over five years. In the latest year (FY 2025) revenue rose 41%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Acubiosys is 36AAPCA3353G1ZM, registered in Telangana.
The CIN (Corporate Identification Number) of Acubiosys is U73100TG2017PTC115047. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acubiosys was incorporated on 08 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Acubiosys has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2020.
The peers of Acubiosys by revenue are Sekkei Bio Private Limited, Vasanthu Biotech Private Limited, Avisa Biotech Private Limited, Relic Biotechnology Private Limited, Nopo Nanotechnologies India Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).
Sreenivasa Kalyan Velpuri ceased to be Additional Director on 19 Sep 2022. Tanaje Venkata Radha Krishna Mullapudi ceased to be Director on 18 Jun 2021. Chelamalla Radhika ceased to be Director on 04 Mar 2021. Acubiosys has 5 board changes on record in total.